# Taysha Gene Therapies Posts Third-Quarter 2026 Loss of $0.10 Per Share

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/55659
Published: 2026-11-12T16:53:38.000Z
Updated: 2026-11-12T16:53:38.000Z
Section: Business

> The net loss per common share was the same on a basic and diluted basis.

Taysha Gene Therapies posted a net loss per common share of $0.10 for the third quarter of 2026. The per-share loss was the same on a basic and diluted basis.